The Swiss medical technology firm Ypsomed is entering a decisive period, marked by the conclusion of a major capital initiative...

Facing heightened consumer pressure to cut spending, spirits giant Diageo is launching a new entry-level brand to its portfolio. The...

While Ørsted has successfully executed an operational turnaround, its future ownership structure faces renewed scrutiny. The upcoming Danish parliamentary election...

A significant policy shift in Canada is providing a substantial boost to First Phosphate. The company is now positioned at...

Kiplin Metals Inc. has initiated a strategic leadership change to position the company for its upcoming exploration phases. The appointment...

Appia Rare Earths & Uranium is positioning itself as a key supplier in the critical minerals sector, driven by global...

For shareholders of Medical Properties Trust (MPT), the investment thesis remains complex. The company's recent ex-dividend date provided a short-term...

Oracle's latest quarterly earnings report delivered a powerful one-two punch: significant outperformance on key metrics, coupled with a bold and...

A record-breaking quarter and explosive growth in artificial intelligence were not enough to prevent a sharp sell-off in Adobe shares....

As Sangamo Therapeutics advances its gene therapy candidate for Fabry disease, investor focus is split between imminent regulatory milestones and...